18-480
Showing 1 - 25 of >10,000
Influenza Trial (OVX836 480µg, Saline Solution)
Not yet recruiting
- Influenza
- OVX836 480µg
- Saline Solution
- (no location specified)
Oct 5, 2022
Influenza Trial in Raymond Terrace (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Brand 1), Quadrivalent Inactivated
Not yet recruiting
- Influenza
- OVX836 480µg
- +3 more
-
Raymond Terrace, Brisbane, AustraliaMater Misericordiae University Hospital
Feb 9, 2023
Influenza Trial in Ghent (OVX836-003, Saline solution)
Recruiting
- Influenza
- OVX836-003
- Saline solution
-
Ghent, BelgiumCentre for Vaccinology (CEVAC)
Apr 27, 2022
Meningococcal Meningitis Trial in Surabaya (batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of
Not yet recruiting
- Meningococcal Meningitis
- batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4)
- +3 more
-
Surabaya, IndonesiaHusada Utama Hospital
Nov 13, 2023
Poliomyelitis Trial in Panama City (Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3), Sabin Monovalent Oral
Not yet recruiting
- Poliomyelitis
- Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
- Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
-
Panama City, Panama
- +3 more
Dec 14, 2022
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- +2 more
-
Birmingham, Alabama
- +130 more
Dec 22, 2022
Ulcerative Colitis Trial in Worldwide (CP-690,500 5 mg, CP-690,550 10 mg)
Terminated
- Ulcerative Colitis
- CP-690,500 5 mg
- CP-690,550 10 mg
-
Mobile, Alabama
- +79 more
Aug 3, 2022
Diabetes, Hepatitis C, Chronic, Cardiovascular Diseases Trial run by the National Institute of Diabetes and Digestive and Kidney
Recruiting
- Diabetes Mellitus
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Not yet recruiting
- Prostate Cancer
- Biochemically Recurrent
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Blood Pressure Trial (magnesium glycinate supplement, )
Not yet recruiting
- Blood Pressure
- magnesium glycinate supplement
- placebo
- (no location specified)
Jan 10, 2023
Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)
Recruiting
- Pemphigus Vulgaris
- Pemphigus Foliaceus
- efgartigimod PH20 SC
- prednisone
-
Birmingham, Alabama
- +120 more
Dec 22, 2022
Coccidioidomycosis Trial in San Antonio (Placebo, VT-1598)
Completed
- Coccidioidomycosis
- Placebo
- VT-1598
-
San Antonio, TexasICON Early Phase Services Clinical Research Unit
Dec 15, 2022
Natural History of Inflammatory Muscle Diseases
Not yet recruiting
- Inflammation In Skeletal Muscle
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 28, 2023
Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- Lung Cancer Stage III
- Nivolumab and Chemotherapy
- +3 more
- (no location specified)
Aug 15, 2023
Healthy Aging Trial in Los Angeles (In-home Preventive Health Visits by Advanced Practice Nurse, On-site Evidence-based Physical
Enrolling by invitation
- Healthy Aging
- In-home Preventive Health Visits by Advanced Practice Nurse
- On-site Evidence-based Physical Activity, Health and Wellness Classes
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 18, 2022
Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)
Not yet recruiting
- Prostate Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Lennox Gastaut Syndrome (LGS) Trial in Worldwide (Soticlestat, Placebo)
Recruiting
- Lennox Gastaut Syndrome (LGS)
- Soticlestat
- Placebo
-
Phoenix, Arizona
- +109 more
Jan 10, 2023
Biochemical Recurrent Prostate Cancer Trial run by the National Cancer Institute (NCI) (Radium-223, 18F Sodium Fluoride)
Recruiting
- Biochemical Recurrent Prostate Cancer
- Radium-223
- 18F Sodium Fluoride
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023